-
1
-
-
79959746261
-
Sphingolipids: Agents provocateurs in the pathogenesis of insulin resistance
-
21468641 10.1007/s00125-011-2127-3 1:CAS:528:DC%2BC3MXntFGrsLc%3D
-
Lipina C, Hundal HS (2011) Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance. Diabetologia 54:1596-1607
-
(2011)
Diabetologia
, vol.54
, pp. 1596-1607
-
-
Lipina, C.1
Hundal, H.S.2
-
2
-
-
63249117466
-
Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance
-
19008343 10.2337/db08-1228 1:CAS:528:DC%2BD1MXhslersLY%3D
-
Haus JM, Kashyap SR, Kasumov T et al (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58:337-343
-
(2009)
Diabetes
, vol.58
, pp. 337-343
-
-
Haus, J.M.1
Kashyap, S.R.2
Kasumov, T.3
-
3
-
-
70949101414
-
Link between plasma ceramides, inflammation and insulin resistance: Association with serum IL-6 concentration in patients with coronary heart disease
-
19669729 10.1007/s00125-009-1482-9 1:CAS:528:DC%2BD1MXhsVWls7vL
-
de Mello VD, Lankinen M, Schwab U et al (2009) Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 52:2612-2615
-
(2009)
Diabetologia
, vol.52
, pp. 2612-2615
-
-
De Mello, V.D.1
Lankinen, M.2
Schwab, U.3
-
4
-
-
33751202982
-
Association of ceramides in human plasma with risk factors of atherosclerosis
-
DOI 10.1007/s11745-006-5041-6
-
Ichi I, Nakahara K, Miyashita Y et al (2006) Association of ceramides in human plasma with risk factors of atherosclerosis. Lipids 41:859-863 (Pubitemid 44788907)
-
(2006)
Lipids
, vol.41
, Issue.9
, pp. 859-863
-
-
Ichi, I.1
Nakahara, K.2
Miyashita, Y.3
Hidaka, A.4
Kutsukake, S.5
Inoue, K.6
Maruyama, T.7
Miwa, Y.8
Harada-Shiba, M.9
Tsushima, M.10
Kojo, S.11
-
5
-
-
64349124701
-
Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
-
18832345 10.1194/jlr.D800028-JLR200 1:CAS:528:DC%2BD1MXitlCqtbg%3D
-
Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G (2009) Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 50:574-585
-
(2009)
J Lipid Res
, vol.50
, pp. 574-585
-
-
Wiesner, P.1
Leidl, K.2
Boettcher, A.3
Schmitz, G.4
Liebisch, G.5
-
6
-
-
0029031099
-
Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion
-
7775441 10.1074/jbc.270.23.13834 1:CAS:528:DyaK2MXmt1yqsLs%3D
-
Merrill AH Jr, Lingrell S, Wang E, Nikolova-Karakashian M, Vales TR, Vance DE (1995) Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion. J Biol Chem 270:13834-13841
-
(1995)
J Biol Chem
, vol.270
, pp. 13834-13841
-
-
Merrill, Jr.A.H.1
Lingrell, S.2
Wang, E.3
Nikolova-Karakashian, M.4
Vales, T.R.5
Vance, D.E.6
-
7
-
-
33847332202
-
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
-
17339025 10.1016/j.cmet.2007.01.002 1:CAS:528:DC%2BD2sXjsF2qtL8%3D
-
Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167-179
-
(2007)
Cell Metab
, vol.5
, pp. 167-179
-
-
Holland, W.L.1
Brozinick, J.T.2
Wang, L.P.3
-
8
-
-
77956022194
-
Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption
-
20522596 10.2337/db09-1293 1:CAS:528:DC%2BC3cXhsVGhs7nI
-
Ussher JR, Koves TR, Cadete VJ et al (2010) Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59:2453-2464
-
(2010)
Diabetes
, vol.59
, pp. 2453-2464
-
-
Ussher, J.R.1
Koves, T.R.2
Cadete, V.J.3
-
9
-
-
33750590489
-
Altered adipose and plasma sphingolipid metabolism in obesity: A potential mechanism for cardiovascular and metabolic risk
-
DOI 10.2337/db06-0330
-
Samad F, Hester KD, Yang G, Hannun YA, Bielawski J (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55:2579-2587 (Pubitemid 44871159)
-
(2006)
Diabetes
, vol.55
, Issue.9
, pp. 2579-2587
-
-
Samad, F.1
Hester, K.D.2
Yang, G.3
Hannun, Y.A.4
Bielawski, J.5
-
10
-
-
67649687040
-
Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis
-
19387108
-
Lyn-Cook LE Jr, Lawton M, Tong M et al (2009) Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. J Alzheimers Dis 16:715-729
-
(2009)
J Alzheimers Dis
, vol.16
, pp. 715-729
-
-
Lyn-Cook, Jr.L.E.1
Lawton, M.2
Tong, M.3
-
11
-
-
0022970190
-
Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells
-
Preiss J, Loomis CR, Bishop WR, Stein R, Niedel JE, Bell RM (1986) Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem 261:8597-8600 (Pubitemid 17205050)
-
(1986)
Journal of Biological Chemistry
, vol.261
, Issue.19
, pp. 8597-8600
-
-
Preiss, J.1
Loomis, C.R.2
Bishop, W.R.3
-
12
-
-
33645842245
-
Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues
-
16396984 10.1210/en.2005-1074 1:CAS:528:DC%2BD28XjvFOrtLw%3D
-
Watt MJ, Hevener A, Lancaster GI, Febbraio MA (2006) Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues. Endocrinology 147:2077-2085
-
(2006)
Endocrinology
, vol.147
, pp. 2077-2085
-
-
Watt, M.J.1
Hevener, A.2
Lancaster, G.I.3
Febbraio, M.A.4
-
13
-
-
79959434733
-
Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase
-
21464445 10.2337/db10-0845 1:CAS:528:DC%2BC3MXmsVKltbc%3D
-
Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ (2011) Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 60:1458-1466
-
(2011)
Diabetes
, vol.60
, pp. 1458-1466
-
-
Borg, M.L.1
Andrews, Z.B.2
Duh, E.J.3
Zechner, R.4
Meikle, P.J.5
Watt, M.J.6
-
14
-
-
67650517066
-
An improved method to determine serine palmitoyltransferase activity
-
19181628 10.1194/jlr.D900001-JLR200 1:CAS:528:DC%2BD1MXms1ehtLY%3D
-
Rutti MF, Richard S, Penno A, von Eckardstein A, Hornemann T (2009) An improved method to determine serine palmitoyltransferase activity. J Lipid Res 50:1237-1244
-
(2009)
J Lipid Res
, vol.50
, pp. 1237-1244
-
-
Rutti, M.F.1
Richard, S.2
Penno, A.3
Von Eckardstein, A.4
Hornemann, T.5
|